{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:59:15Z","timestamp":1781211555311,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Medical Center Asan Institute for Life Sciences","doi-asserted-by":"publisher","award":["2021IL0028"],"award-info":[{"award-number":["2021IL0028"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019M3E5D3071926"],"award-info":[{"award-number":["NRF-2019M3E5D3071926"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lungcan.2025.108445","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:53:18Z","timestamp":1739310798000},"page":"108445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma implicate the needs for tailored treatment strategies"],"prefix":"10.1016","volume":"201","author":[{"given":"Bokyung","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deokhoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-2770","authenticated-orcid":false,"given":"Wonjun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-1382","authenticated-orcid":false,"given":"Sung-Min","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Sang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2024","key":"10.1016\/j.lungcan.2025.108445_b0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lungcan.2025.108445_b0010","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.2012.45.3753","article-title":"Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies","volume":"31","author":"Li","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108445_b0015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review","volume":"322","author":"Arbour","year":"2019","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.lungcan.2025.108445_b0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12885-021-08096-w","article-title":"Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom","volume":"21","author":"Lester","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2025.108445_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-019-0731-8","article-title":"Emerging therapies for non-small cell lung cancer","volume":"12","author":"Zhang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lungcan.2025.108445_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107536","article-title":"Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: propensity-matched analysis","volume":"190","author":"Jung","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108445_b0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.lungcan.2025.108445_b0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-017-2148-5","article-title":"SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)\/CK7(pos)\/HepPar-1(pos) immunophenotype","volume":"471","author":"Agaimy","year":"2017","journal-title":"Virchows Arch."},{"key":"10.1016\/j.lungcan.2025.108445_b0045","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108445_b0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108445_b0055","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Can. Med."},{"key":"10.1016\/j.lungcan.2025.108445_b0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","article-title":"Clinicopathologic characteristics of BRG1-Deficient NSCLC","volume":"15","author":"Dagogo-Jack","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108445_b0065","unstructured":"WHO Classification of Tumours Editorial Board. Thoracic Tumours. fifth ed. Lyon: International Agency for Research on Cancer; 2021."},{"key":"10.1016\/j.lungcan.2025.108445_b0070","doi-asserted-by":"crossref","unstructured":"S. Lantuejoul, M. Sound-Tsao, W.A. Cooper, N. Girard, F.R. Hirsch, A.C. Roden, et al., PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee, J Thorac Oncol 15 (2020) 499-519, http:\/\/dx.doi.org\/10.1016\/j.jtho.2019.12.107.","DOI":"10.1016\/j.jtho.2019.12.107"},{"key":"10.1016\/j.lungcan.2025.108445_b0075","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.lungcan.2025.108445_b0080","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkw227","article-title":"VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research","volume":"44","author":"Lai","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lungcan.2025.108445_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.lungcan.2025.108445_b0090","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1093\/nar\/gku1211","article-title":"BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers","volume":"43","author":"Abo","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lungcan.2025.108445_b0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lungcan.2025.108445_b0100","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.lungcan.2025.108445_b0105","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1038\/s41467-020-19402-8","article-title":"Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients","volume":"11","author":"Fernando","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2025.108445_b0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2025.108445_b0115","doi-asserted-by":"crossref","unstructured":"G.K. Smyth, Linear models and empirical bayes methods for assessing differential expression in microarray experiments, Stat Appl Genet Mol Biol 3 (2004) Article3, http:\/\/dx.doi.org\/10.2202\/1544-6115.1027.","DOI":"10.2202\/1544-6115.1027"},{"key":"10.1016\/j.lungcan.2025.108445_b0120","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.lungcan.2025.108445_b0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.lungcan.2022.07.003","article-title":"Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma","volume":"170","author":"Ahn","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108445_b0130","article-title":"An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma","volume":"18","author":"Kim","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2025.108445_b0135","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1245\/s10434-021-10122-x","article-title":"Blood vessel invasion predicts postoperative survival outcomes and systemic recurrence regardless of location or blood vessel type in patients with lung adenocarcinoma","volume":"28","author":"Lee","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.lungcan.2025.108445_b0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4132\/jptm.2021.05.11","article-title":"SMARCA4\/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non-small cell lung cancer","volume":"55","author":"Mehta","year":"2021","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.lungcan.2025.108445_b0145","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.24296","article-title":"Cancer\/testis antigen CT45: analysis of mRNA and protein expression in human cancer","volume":"124","author":"Chen","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2025.108445_b0150","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/PAS.0000000000001944","article-title":"PRAME expression in cancer. a systematic immunohistochemical study of >5800 epithelial and nonepithelial tumors","volume":"46","author":"Kaczorowski","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2025.108445_b0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/modpathol.2012.195","article-title":"Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma","volume":"26","author":"Rekhtman","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2025.108445_b0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2014.07.018","article-title":"Vulnerabilities of mutant SWI\/SNF complexes in cancer","volume":"26","author":"Helming","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2025.108445_b0165","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1038\/ncomms14648","article-title":"The SWI\/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers","volume":"8","author":"Alver","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2025.108445_b0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.3746","article-title":"SMARCB1-mediated SWI\/SNF complex function is essential for enhancer regulation","volume":"49","author":"Wang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lungcan.2025.108445_b0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","article-title":"SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses","volume":"43","author":"Perret","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2025.108445_b0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-022-02128-z","article-title":"Autologous T cell therapy for MAGE-A4(+) solid cancers in HLA-A*02(+) patients: a phase 1 trial","volume":"29","author":"Hong","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2025.108445_b0185","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamaophthalmol.2017.0729","article-title":"PRAME as a potential target for immunotherapy in metastatic uveal melanoma","volume":"135","author":"Gezgin","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.lungcan.2025.108445_b0190","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2025.108445_b0195","doi-asserted-by":"crossref","first-page":"12249","DOI":"10.1073\/pnas.1703966114","article-title":"PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI\/SNF mutant tumors","volume":"114","author":"Januario","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.lungcan.2025.108445_b0200","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1158\/1078-0432.CCR-15-1468","article-title":"SMARCA4\/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer","volume":"22","author":"Bell","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108445_b0205","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108445_b0210","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Wistuba, II, et al., Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.lungcan.2025.108445_b0215","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jtho.2021.03.024","article-title":"SMARCA4 and Other SWItch\/sucrose nonfermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition","volume":"16","author":"Alessi","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108445_b0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2022.05.001","article-title":"SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils","volume":"169","author":"Velut","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108445_b0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.semdp.2021.06.001","article-title":"Recent updates in thoracic SMARCA4-deficient undifferentiated tumor","volume":"38","author":"Nambirajan","year":"2021","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.lungcan.2025.108445_b0230","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/PAS.0000000000000558","article-title":"Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type","volume":"40","author":"Conlon","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lungcan.2025.108445_b0235","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.annonc.2020.08.2105","article-title":"KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden","volume":"31","author":"Marinelli","year":"2020","journal-title":"Ann. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T09:45:07Z","timestamp":1743846307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":47,"alternative-id":["S0169500225000662"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108445","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma implicate the needs for tailored treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108445"}}